ECM
GRCL

ExodusPoint Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

ExodusPoint Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-87,529
Closed -$481K – 2348
2022
Q2 		$481K Buy
+87,529
New +$481K 0.01% 1330
2021
Q4 		– Sell
-14,700
Closed -$204K – 2656
2021
Q3 		$204K Buy
+14,700
New +$204K ﹤0.01% 1723